![](/img/cover-not-exists.png)
Su1860 HIGHER VEDOLIZUMAB SERUM LEVELS DO NOT INCREASE THE RISK OF ADVERSE EVENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Sengupta, Neil K., Azizov, Ahmad, Halder, Smita, Xenodemetropoulos, Ted, Armstrong, David, Tse, Frances, Marshall, John K., Narula, NeerajVolume:
158
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(20)32387-8
Date:
May, 2020
File:
PDF, 1.15 MB
2020